Primary patient samples of GCB-DLBCL exhibited enhanced MNK1 expression consistent with cell line data, and, notably, undetectable MNK2 levels (Fig. 1c,d). This evidence concerns the gene MKNK2 and diffuse large B-cell lymphoma.